JPS6210087A - ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤 - Google Patents

４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤

Info

Publication number
JPS6210087A
JPS6210087A JP60147054A JP14705485A JPS6210087A JP S6210087 A JPS6210087 A JP S6210087A JP 60147054 A JP60147054 A JP 60147054A JP 14705485 A JP14705485 A JP 14705485A JP S6210087 A JPS6210087 A JP S6210087A
Authority
JP
Japan
Prior art keywords
methyl
formula
linear
branched alkyl
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60147054A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0556358B2 (2
Inventor
Ikuo Adachi
足達　郁夫
Yoshiharu Hiramatsu
義春 平松
Motohiko Ueda
元彦 上田
Masaru Kawakami
勝 川上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP60147054A priority Critical patent/JPS6210087A/ja
Priority to US06/876,120 priority patent/US4703051A/en
Priority to DE8686108103T priority patent/DE3683549D1/de
Priority to EP86108103A priority patent/EP0207345B1/en
Priority to KR1019860005357A priority patent/KR930005175B1/ko
Priority to DK198603154A priority patent/DK174026B1/da
Priority to GB8616238A priority patent/GB2177400B/en
Publication of JPS6210087A publication Critical patent/JPS6210087A/ja
Publication of JPH0556358B2 publication Critical patent/JPH0556358B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60147054A 1985-07-03 1985-07-03 ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤 Granted JPS6210087A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP60147054A JPS6210087A (ja) 1985-07-03 1985-07-03 ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤
US06/876,120 US4703051A (en) 1985-07-03 1986-06-02 4,7-dihydrothieno[2,3-B]pyridine derivatives useful in the treatment of cardiovascular diseases
DE8686108103T DE3683549D1 (de) 1985-07-03 1986-06-13 4,7-dihydrothieno(2,3-b)pyridinderivate, verfahren zu ihrer herstellung und mittel fuer kardiovaskulaere krankheiten.
EP86108103A EP0207345B1 (en) 1985-07-03 1986-06-13 4,7-Dihydrothieno[2,3-b]pyridine derivatives, process thereof, and agents for cardiovascular diseases
KR1019860005357A KR930005175B1 (ko) 1985-07-03 1986-07-02 4,7-디히드로티에노 [2,3-b] 피리딘 유도체의 제조방법
DK198603154A DK174026B1 (da) 1985-07-03 1986-07-02 4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser
GB8616238A GB2177400B (en) 1985-07-03 1986-07-03 4,7-dihydrothieno[2,3-b]pyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60147054A JPS6210087A (ja) 1985-07-03 1985-07-03 ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤

Publications (2)

Publication Number Publication Date
JPS6210087A true JPS6210087A (ja) 1987-01-19
JPH0556358B2 JPH0556358B2 (2) 1993-08-19

Family

ID=15421457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60147054A Granted JPS6210087A (ja) 1985-07-03 1985-07-03 ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤

Country Status (7)

Country Link
US (1) US4703051A (2)
EP (1) EP0207345B1 (2)
JP (1) JPS6210087A (2)
KR (1) KR930005175B1 (2)
DE (1) DE3683549D1 (2)
DK (1) DK174026B1 (2)
GB (1) GB2177400B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097118A1 (ja) * 2004-04-05 2005-10-20 Takeda Pharmaceutical Company Limited アルドステロン受容体拮抗剤
JP2007519625A (ja) * 2003-12-23 2007-07-19 ダウ アグロサイエンシィズ エルエルシー ピリジン誘導体の調製方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4874760A (en) * 1987-01-09 1989-10-17 Toa Eiyo, Ltd. 4,7-dihydroisothiazolo(5,4-b)pyridine derivatives and cardiovascular treating agents containing said derivatives
GB8801491D0 (en) * 1988-01-22 1988-02-24 Beecham Group Plc Novel compounds
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
ATE103806T1 (de) * 1990-07-04 1994-04-15 Shionogi & Co Verfahren zur herstellung einer nichtkohaesiven ueberzugsschicht.
JP2632754B2 (ja) * 1991-05-21 1997-07-23 塩野義製薬株式会社 脳内グルタミン酸遊離抑制剤
US6037340A (en) * 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
JP3046589U (ja) * 1997-08-26 1998-03-10 株式会社三栄マシニング モンキ−スパナ−
JP2009520833A (ja) * 2005-12-20 2009-05-28 ギリード・コロラド・インコーポレーテッド ４，７−ジヒドロチエノ［２，３−ｂ］ピリジン化合物及び医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310746A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DD210278A5 (de) * 1982-03-05 1984-06-06 Boehringer Ingelheim Kg Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007519625A (ja) * 2003-12-23 2007-07-19 ダウ アグロサイエンシィズ エルエルシー ピリジン誘導体の調製方法
WO2005097118A1 (ja) * 2004-04-05 2005-10-20 Takeda Pharmaceutical Company Limited アルドステロン受容体拮抗剤

Also Published As

Publication number Publication date
DK315486A (da) 1987-01-04
GB8616238D0 (en) 1986-08-13
KR930005175B1 (ko) 1993-06-16
DE3683549D1 (de) 1992-03-05
JPH0556358B2 (2) 1993-08-19
EP0207345A3 (en) 1988-02-24
GB2177400A (en) 1987-01-21
DK174026B1 (da) 2002-04-29
EP0207345A2 (en) 1987-01-07
US4703051A (en) 1987-10-27
GB2177400B (en) 1989-04-05
KR870001214A (ko) 1987-03-12
DK315486D0 (da) 1986-07-02
EP0207345B1 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
AU645504B2 (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
KR100217167B1 (ko) 신규 벤조피란 유도체
SU1584750A3 (ru) Способ получени производных 3(2Н)-пиридазинона
US4576958A (en) Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
JP7604018B2 (ja) 化合物、その薬学的に許容される塩又は立体異性体、及びその使用
JPS6210087A (ja) ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤
JP2707936B2 (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
US5145850A (en) Imidazopyridazines, their production and use
JPS5965089A (ja) ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
SK47894A3 (en) 2-amino-4-chinolyl-dihydropyridines, method of their production treatments containing thereof, method of their production, and using of these compounds
US20050245750A1 (en) Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
EP0440119A1 (en) Imidazopyridazine compounds, their production and use
CZ177892A3 (en) AMINOMETHYL SUBSTITUTED 2,3-DIHYDROPYRAN(2,3-b)PYRIDINES, PROCESS OF THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
KR920005827B1 (ko) 벤조티아디아제핀 유도체
SU1421258A3 (ru) Способ получени транс-октагидрооксазоло(4,5 @ )хинолина или его фармацевтически приемлемых солей
US4372956A (en) 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them
RU2036924C1 (ru) Способ получения производных имидазо (1,2-b)пиридазина или их солей и производные имидазо (1,2-b)пиридазина или их соли
JP2875605B2 (ja) ３―エキソメチレンピロロ［２，１―ｂ］チアゾール誘導体
EP0157260B1 (en) 4,7-dihydropyrazolo(3,4-b)pyridine derivatives
WO2019218998A1 (zh) 一种丙烯酸酯化合物及其用途
SE439164B (sv) 1,1-disubstituerade oktahydro-indolo(2,3-a)kinoliziner och farmaceutisk beredning innehallande dem
JP3553158B2 (ja) ピリダジノインドール誘導体
CA1292991C (en) 4,7-dihydrothieno[2,3-b]pyridine derivatives process thereof and agents for cardiovascular diseases
EP0668276A1 (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivative, process for producing the same, and use thereof